Key result
Elevated Lipoprotein(a) is a genetically determined risk factor for cardiovascular disease with substantial inter-ethnic variation, highlighting the need for screening in high-risk patients.
Why the study?
Substantial inter-ethnic variation exists in Lp(a) levels, and further study is needed to establish a causal relationship between elevated Lp(a) and cardiovascular disease across diverse ethnic populations.
Screening for elevated Lp(a) is increasingly important in patients with a history of ASCVD, especially given the advent of novel targeted therapies.
Answers are grounded in this paper and cite their sources.
Lp(a) screening may refine risk assessment across ethnic groups; extends Mendelian randomization causality but leaves optimal thresholds and therapy impact open.
Lipoprotein(a) (Lp(a)) is a highly proatherogenic lipid fraction that is genetically determined and minimally responsive to lifestyle or behavior changes. Mendelian randomization studies have suggested a causal link between elevated Lp(a) and heart disease, stroke, and aortic stenosis. There is substantial inter-ethnic variation in Lp(a) levels, with persons of African descent having the highest median values. Monitoring of Lp(a) has historically been limited by lack of standardization of assays. With the advent of novel therapeutic modalities to lower Lp(a) levels including proprotein convertase subtilisin/kexin 9 (PCSK9) inhibitors and targeted antisense oligonucleotides, it is increasingly important to screen patients who have family or personal history of atherosclerotic cardiovascular disease for elevations in Lp(a). Further study is needed to establish a causal relationship between elevated Lp(a) and cardiovascular disease across diverse ethnic populations.
No takes yet. Share an insight, caveat, or question.
Pearson et al. (2020) conducted a review in Cardiovascular Disease. Lipoprotein(a) screening and targeted therapies was evaluated. Elevated Lipoprotein(a) is a genetically determined risk factor for cardiovascular disease with substantial inter-ethnic variation, highlighting the need for screening in high-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: